India’s Biosimilars Guidelines Lay Out Best Practices But Marketed Products Not To Be Reviewed – BIO Conference
This article was originally published in The Pink Sheet Daily
Executive Summary
The guidelines will enable a standardized biosimilars pathway as opposed to case-by-case application reviews